David Sinclair: GLP-1 Side Effect No One Talks About, AI in His Lab & Reversing Blindness | EP #251
Is it worth your time?
You get a detailed account of how AI-driven drug design and OSK gene therapies are being deployed to reverse aging and restore vision in clinical models.
This conversation explores how AI, gene therapies, and metabolic treatments can reverse cellular aging and combat degenerative diseases. Sinclair details concrete biotechnology applications designed to extend human health span.
AI and OSK therapy. Sinclair argues that AI accelerates drug discovery exponentially by analyzing millions of cells within about 10 minutes. He expects that OSK therapy will render conditions like macular degeneration reversible, pointing to animal models where motor neurons regrew back to the muscle.
Genetics and longevity. Sinclair maintains that at least half of an individual's lifespan is influenced by lifestyle choices rather than strict genetics. He notes that whole genome sequencing remains vital for identifying actionable risks, allowing proactive medical monitoring to prevent acute health failures.
GLP-1 and aging. Sinclair warns that severe overweightness accelerates the pace of aging, causing roughly 20,000 to 30,000 people in the US annually to lose their sight. He points out that GLP-1 delivers substantial benefits to the heart and brain beyond simple weight reduction.
Sleep and Exercise
You and I differentiate on sleep and exercise; I try to get eight hours of sleep and be in the gym five days a week. I would sleep and exercise more if I weren't traveling on an airplane most of the time.
I have a standing desk and a treadmill at home where I try to read and work while walking. However, life takes over; Serena and I spend a lot of time traveling because we want to educate the world and have the opportunity to meet world and industry leaders.
The Hayflick Limit and Longevity
It is a mission, and I'm sacrificing my health for that.
The Hayflick limit occurs when cells divide too many times and run out of telomere length at the ends of the chromosomes. We see evidence that turning on OSK activates telomerase and lengthens the telomeres. If that is not the answer, we could combine our treatment with telomerase therapy to potentially get even longer life for the cells in our body.
GLP-1 and Aging
More data shows benefits to the heart and brain beyond just weight loss. If you are not overweight or do not want to lose weight, talk to your doctor about microdosing, as this must be doctor supervised.
Weight loss alone is actually the biggest benefit you can have for longevity. While not socially polite to say, being massively overweight accelerates your pace of aging. An increasing number of people—about 20,000 to 30,000 in the US a year—are waking up blind because of it. This is one of the conditions where ER100 therapy will be tested to see if we can reverse blindness caused by neon drugs.
Benefits of Eating Stressed Plants
Conrad Howitz and I published the xenohormesis hypothesis about 15 to 20 years ago. The idea sprung from our work in the early 2000s showing that resveratrol and plant polyphenols—like quercetin and fisetin—could activate the SIRT1 enzyme. Most 20th-century pharmaceuticals were derived from natural molecules, and we believe we evolved to sense stress in the plant world as a heads-up to hunker down for starvation.
When you eat stressed plants, the high level of polyphenols signals adversity. As Serena would say, "Eat the rainbow" by choosing colored plants, dark leafy greens, and colored vegetables. My favorite right now is broccolini, very lightly steamed with olive oil and lemon, or just salt and pepper. Bitter olive oils are also full of these polyphenols.
I'm calling from Israel, where we are working with companies and academics doing a lot of AI. While I haven't worked with Jeff or used Lila yet, we hope to. My lab cannot survive without AI; it is accelerating our work exponentially.
AI Driven Drug Design
We're doing now what would have taken hundreds of years before. Our work includes AI-driven drug design, screening billions and eventually trillions of molecules to see which ones might reverse aging. We use AI to determine whether a cell is old or young just by looking at it, allowing us to analyze millions of cells within about 10 minutes.
In another area, we submitted a paper on our collaboration with a group called Cadence. Cadence is a genetic system we use for longevity; we fed it transcriptomic data, and it discovered a way to look at biological age that we hadn't thought of. We are using AI as scientists to give us ideas and be creative. If anyone tells you AI can only do what we've taught it, that is the biggest bunch of BS you'll ever hear. AI can be just as smart and creative as we are, and even more so in the future.
Genetics, Longevity and Mindset
Longevity often runs in families; when one person is a centenarian, others often are as well. A recent paper challenged the idea that only 10 to 15% of our lifespan is genetically determined, suggesting it is closer to 50/50. At a minimum, science says at least half of your lifespan is up to you, while the rest may be determined.
Serena and I have weighed ourselves down with wearables, which is the future of health. Companies like Peters are already allowing the pointy end of the spear to do this, but eventually it will be normal to be monitored and told ahead of time if you might have a heart attack next week so you can get medicine before it happens.
Most physicians don't bother doing whole genome or exome sequencing, but they should because it is important. I am working to educate doctors about which genes are important to look at, what is actionable, and what is just for fun. At Fountain, we look at two things immediately: what is going on inside your body that you need to know right now, and what is likely to happen in the future so we can optimize you.
I put genetics into two categories. Lifestyle impacts your first 70-80 years, preventing you from dying from something stupid. If you are going from 80 to 100 or 110, genetics play an outsized part. Therapeutics coming out of David's lab and others are about overcoming your genetics to go further. Your genetics will tell you what to focus on and change.
My father was the best example. With Ashkenazi Jewish heritage, our genome sucks; my ancestors typically died in their 70s, and my grandmother had a stroke in her 30s. The fact that my father now lives healthily beyond any of his ancestors is testament that you can change what your genes have given you.
We run 22 care centers with 1,600 residents—wonderful older people with an average age of 90. The oldest person in the world, Ethel Catram, who is 116 and going strong, lives with us.
I mentioned nattokinase, which is probably the most natural way to do it. Evidence shows that lowering LDL sufficiently can have reversal effects, especially if you get inflammation down. While there is a sweet spot for LDL, getting rid of it is not a science-based goal. If you have high LDL, try to get it really low using medicines better than statins, like PCSK9 inhibitors and others to come, though I haven't seen anything as powerful as nattokinase in the literature.
Your mindset matters: your belief that you can live longer, that a revolution is coming, that you are needed in society, and that you have purpose. A National Academy of Sciences study found that optimists lived 15% longer than pessimists.
This is Ipek from Istanbul, Turkey.
What KPIs in Longevity Should We Pay Attention To?
The team counts for probably 50% of my investment decisions. I also look at cash on hand, valuation, and their runway. Biotech needs to raise a lot of money to succeed, and capital deficiency is their number one cause of mortality, so you don't want them struggling for cash. I consider how far advanced they are—whether they are near the clinic or another 10 years away.
A team's reputation is where everything stems from. Biotech is like a maze; if you've done it before, you know the way and the wormholes to go quicker. An inexperienced team, such as a group just out of academia, faces a challenging path unless they have really good mentors, which I've been fortunate to see over the years. Reputation also counts because money follows the reputation of the people, and a track record of raising money is helpful.
The Role of Building Muscles in Longevity
If anyone is interested, you could look at the work of Shalender Bhasin, who has run many trials particularly on testosterone. The summary of his work, spanning decades, is that testosterone doesn't extend lifespan or act as an anti-aging agent, but it does prevent falls and benefits your overall metabolic, muscular, and skeletal health. Many people become frail and die from falling and breaking bones, making the last ten years of their life unpleasant.
If you are low on DHEA, you can fix that with a supplement. There is also a lot of good evidence that hormone replacement for women is not dangerous in the way previously thought; the old study suggesting it might cause cancer has been disregarded.
OSK Therapy for Neurodegenerative Disease
Regarding the variations of ALS and Lou Gehrig's disease, I can discuss the results in animal models. The surprising thing about OSK ER100 therapy is that it works across such broad diseases. Kelly Rich, a remarkable postdoc known to the Friends of Sinclair Lab, is working on ALS and using aging as a model because we see degeneration of motor neurons. Kelly is finding that the regrowth of motor neurons back to the muscle is possible using OSK therapy and even with the chemical compound cocktail. This suggests the disease may not always be progressive; we are showing in animals, I think for the first time, that it is a reversible condition.
We have a lot of data on this at Life Biosciences. My former student Wang Tang Lu, who went to MIT, has a paper he hopes to publish soon. Through work in my lab and in collaboration with a Korean lab, all three of us have shown that both wet and dry macular degeneration are reversible to some extent in gold standard animal models. Consequently, Life Biosciences is looking to try ER100 in those diseases, pending results in glaucoma.
The Void Between Mindset and Science
I read your book in 2019 and believed I would live until 120. Then I met my wife, who pushed me to 150 and the belief that longevity escape velocity is coming soon. I believe in the power of mindset, but research from leaders in science seems physical, physiological, biological, measurable, and empirical. We think these things are objective, yet mindset remains subjective. I see a void between the two, and while people like Joe Dispenza do powerful subjective work, I wonder how you view this gap. I have also started meditating thanks to your wife.
Serena introduced me to Joe's work. We are trying to bridge that gap; Serena was the inspiration, telling me the mind can change everything and improve the immune system. I didn't believe her, but she argued that what exists in metaphysical "woo-woo" spaces often turns out to be real later, with scientists just trailing behind. A few months after that discussion, a paper showed that manipulating nerves in a mouse's brain involved in mental thought sends signals down to the gut, increasing immune cells by changing the brain.
I decided to study it, and my student, Allegra, is manipulating and rejuvenating sensory nerves in the body. We expect to see broad effects that meditation has claimed for potentially thousands of years. I believe there will be evidence, if not proof, of how the mind overcomes matter to do remarkable things, like curing diseases that even medicines cannot.